Advisors Preferred LLC lowered its stake in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 14.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,194 shares of the financial services provider’s stock after selling 729 shares during the quarter. Advisors Preferred LLC’s holdings in Aflac were worth $429,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Spinnaker Trust boosted its stake in shares of Aflac by 2.7% during the third quarter. Spinnaker Trust now owns 3,620 shares of the financial services provider’s stock valued at $405,000 after purchasing an additional 95 shares during the period. Secure Asset Management LLC boosted its stake in shares of Aflac by 1.0% during the third quarter. Secure Asset Management LLC now owns 9,783 shares of the financial services provider’s stock valued at $1,094,000 after purchasing an additional 96 shares during the period. Phillips Wealth Planners LLC boosted its stake in shares of Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock valued at $662,000 after purchasing an additional 100 shares during the period. Raleigh Capital Management Inc. boosted its stake in shares of Aflac by 23.2% during the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after purchasing an additional 100 shares during the period. Finally, New Century Financial Group LLC boosted its stake in shares of Aflac by 2.5% during the third quarter. New Century Financial Group LLC now owns 4,198 shares of the financial services provider’s stock valued at $469,000 after purchasing an additional 101 shares during the period. Institutional investors own 67.44% of the company’s stock.
Insiders Place Their Bets
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the firm’s stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.90% of the stock is currently owned by insiders.
Aflac Stock Performance
Aflac (NYSE:AFL – Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Sell-side analysts expect that Aflac Incorporated will post 6.95 EPS for the current year.
Aflac Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Wednesday, February 19th will be given a dividend of $0.58 per share. The ex-dividend date is Wednesday, February 19th. This is a positive change from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 dividend on an annualized basis and a yield of 2.24%. Aflac’s dividend payout ratio (DPR) is currently 20.83%.
Wall Street Analyst Weigh In
AFL has been the subject of a number of research reports. Wells Fargo & Company upped their price objective on shares of Aflac from $103.00 to $104.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 14th. Evercore ISI lowered their price objective on shares of Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a research note on Wednesday, December 4th. Piper Sandler lowered their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research note on Friday. JPMorgan Chase & Co. upped their price objective on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 7th. Finally, Barclays lowered their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research note on Friday. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $103.21.
Check Out Our Latest Research Report on AFL
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Read More
- Five stocks we like better than Aflac
- Using the MarketBeat Dividend Yield Calculator
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Top Stocks Investing in 5G Technology
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- Differences Between Momentum Investing and Long Term Investing
- MarketBeat Week in Review – 02/03 – 02/07
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.